Oncology Central

Novel blood test could quickly predict breast cancer patient’s response to palbociclib

A novel blood test could predict if breast cancer patients are responding to the recently approved drug palbociclib, months earlier than current tests.

In this study researchers compared the amount of the gene

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.